The liver enzymes, ALT and AST, markers of metabolic dysfunction-associated fatty liver disease (MASLD/MAFLD, i.e., previously non-alcoholic fatty liver disease, NAFLD; [19]) were highest in patients identifying as Hispanic/Latino (ALT M = 97.0 ± 40.6, AST M = 53.6 ± 21.4) and lowest in patients identifying as non-Hispanic/Latino Black (ALT M = 23.1 ± 11.3, AST M = 23.05 ± 11.4). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.